a b s t r a c t
In this data article, we provide subgroup specific baseline characteristics and serum sphingosine-1-phosphate (S1P) concentrations for healthy individuals within the Study of Health in Pomerania (SHIP)-TREND cohort. After exclusion of subjects with cardiovascular disease, diabetes mellitus, hypertension, metabolic syndrome, elevated liver enzymes and/or chronic kidney disease stadium III or IV, four subgroups were defined according to different limits for body mass index (BMI), alterations in blood lipid levels and smoking status. Tables show respective clinical and laboratory parameters stratified by gender. Serum S1P concentrations are also stratified by age groups. The data 
Experimental features
After the definition of different subgroups within the SHIP-TREND cohort, the subgroups were characterized by clinical as well as laboratory parameters and sphingosine-1-phosphate concentrations.
Data source location
Greifswald, Germany Data accessibility Data is with this article.
Value of the data
The data presented in this DIB article provides further insight into subgroup formation and S1P
concentrations depending on BMI limit, altered blood lipid levels and smoking status.
The data will facilitate the determination of S1P reference intervals in future population-based cohorts.
The data can be used for establishing S1P as cardiovascular biomarker.
Data
In this Data in Brief article, we provide clinical as well as laboratory baseline characteristics and serum sphingosine-1-phosphate (S1P) concentrations that extend the results reported in [1] for four different subgroups of healthy individuals within the Study of Health in Pomerania (SHIP)-TREND cohort. In any case, subjects with cardiovascular disease, diabetes mellitus, hypertension, metabolic syndrome, elevated liver enzymes and/or chronic kidney disease stadium III or IV were excluded. With respect to body mass index (BMI), the exclusion limit for the first subgroup was 25 kg/m 2 ('BMI o ¼25', n ¼805; Table 1 ) and 35 kg/m 2 for the second subgroup ('BMI o ¼35', n ¼1474; Table 2 ), respectively. For the third subgroup altered blood lipid levels were an additional exclusion criterion ('Normolipidemia', n ¼740; Table 3 ) and smoking for the fourth subgroup ('Non-Smokers', n ¼ 884; Table 4 ), respectively. Here, in each case the BMI limit was defined as 30 kg/m 2 . All parameters were stratified by gender, median serum S1P
concentrations also by age groups. 
Experimental design, materials and methods

Study population
The population-based SHIP-TREND cohort comprises 4420 inhabitants of West Pomerania. A detailed description of the cohort study can be found in Völzke et al. [2, 3] . The study conformed to the principles of the Declaration of Helsinki and was approved by the Ethics Committee of the University Continuous data are given as median (25th, 75th percentile), Mann-Whitney U-test was used for comparison between women and men. eGFR, estimated glomerular filtration rate; HbA1c, hemoglobin A1c; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
of Greifswald. All participants provided informed written consent. The exclusion criteria for subgroup formation have been precisely defined in [1] .
Clinical and laboratory parameters
Clinical data acquisition and analytical procedures, i.e. for determining laboratory data and S1P concentrations, have been reported previously [1] .
Data analysis
Continuous data are given as median (25th and 75th percentiles). The non-parametric MannWhitney U-test was used for comparison between women and men.
